This compound is primarily used in the synthesis of complex organic molecules, particularly in the pharmaceutical industry. It serves as a key intermediate in the production of peptide-based drugs and other bioactive compounds. The tert-butoxycarbonyl (Boc) and tert-butyldimethylsilyl (TBDMS) protecting groups ensure selective reactivity during multi-step synthesis processes, allowing for precise control over molecular structure. Its chiral nature makes it valuable in the development of enantiomerically pure drugs, enhancing their efficacy and reducing side effects. Additionally, it is employed in research settings for studying amino acid derivatives and their interactions in biological systems.